BetaGlue Therapeutics and its shareholders are proud to collaborate with Fondazione Policlinico Universitario Agostino Gemelli in the fight against cancer. Our clinical study in locally advanced pancreatic cancer is on-going. Learn more with this video.
EANM Annual Congress
October 17-21, 2026 | Austria Center Vienna
Vienna, Austria
Register interest: info@betaglue.com
ESMO Congress
October 25-27, 2026 | IFEMA Madrid
Madrid, Spain
Register interest: info@betaglue.com
LSI Europe Summit
September 28 – October 2, 2026 | Grand Hyatt Barcelona
Barcelona, Spain
Register interest: info@betaglue.com
CIRSE Annual Congress
September 5-9, 2026 | Bella Center Copenhagen
Copenhagen, Denmark
Register interest: info@betaglue.com
European Society for Medical Oncology
July 1-4, 2026 | ICM
Munich, Germany
Register interest: info@betaglue.com
American Society of Clinical Oncology
May 29-June 2, 2026 | McCormick Place
Chicago (IL), USA & Online
Register interest: info@betaglue.com
Annual Scientific Meeting
11-15 April, 2026 | Metro Toronto Convention Centre
Toronto (ON), Canada
Register interest: info@betaglue.com
LSI USA Summit
March 16-20, 2026 | Monarch Beach
Dana Point (CA), USA
Register interest: info@betaglue.com
World Congress of Interventional Oncology
January 26-27, 2026 | Università Cattolica del Sacro Cuore
Rome, Italy
Register interest: info@betaglue.com
Advancements in the fight against cancer
January 15-17, 2026 | JW Marriott Miami
Miami (FL), USA
Register interest: info@betaglue.com
44th Annual J.P. Morgan
January 12-15, 2026 | Westin St. Francis
San Francisco (CA), USA
Register interest: info@betaglue.com
Betty Polikar, Gianluca De Danieli, Pietro Bubba Bello and Gaia Bisaccioni strengthen the Clinical Research, Manufacturing and Quality areas
Read moreAccording to the article featured in the international peer-reviewed journal, BAT-90 could be considered a safe and innovative therapeutic option for unresectable solid liver tumors BetaGlue Technology’s Antonino Amato and…
Read moreThe raised capital will give BetaGlue Technologies the ability to further develop its advanced radiotherapy platform, BAT-90 , thus opening a new chapter in the fight against cancer BetaGlue Technologies…
Read more
